11.1 Information on toxicological effects
Acute toxicity
Oral: No data available
LC50 Inhalation - Rat - male and female - 4 h - 1 - 5 mg/l - dust/mist (OECD Test Guideline 436)
LD50 Dermal - Rabbit - male and female - > 2,000 mg/kg
Remarks: (ECHA)
The value is given in analogy to the following substances: Benzoic acid
Skin corrosion/irritation
Remarks: Causes skin irritation.
(ECHA)
Serious eye damage/eye irritation
Eyes - Rabbit
Result: Causes serious eye irritation.
(OECD Test Guideline 405)
Respiratory or skin sensitization
Maximization Test - Guinea pig
Result: negative (OECD Test Guideline 406)
Germ cell mutagenicity
Test Type: Micronucleus test
Test system: Human lymphocytes
Metabolic activation: with and without metabolic activation
Method: OECD Test Guideline 487
Result: negative
Test Type: In vitro mammalian cell gene mutation test
Test system: mouse lymphoma cells
Metabolic activation: with and without metabolic activation
Method: OECD Test Guideline 490
Result: negative
Carcinogenicity
Classified based on available data. For more details, see section 2
Reproductive toxicity
May damage the unborn child.
Specific target organ toxicity - single exposure
Inhalation - May cause respiratory irritation. - Lungs
Specific target organ toxicity - repeated exposure
Classified based on available data. For more details, see section 2
Aspiration hazard
Classified based on available data. For more details, see section 2
11.2 Additional Information
Repeated dose toxicity - Rat - male and female - Oral - 103 Weeks - NOAEL (No observed adverse effect level) - 400 mg/kg
Remarks: (ECHA)
After absorption:
Damage to:
Kidney
Systemic effects:
Headache
Drowsiness
Convulsions
Dizziness
Shortness of breath
Unconsciousness narcosis
Other dangerous properties can not be excluded.
Handle in accordance with good industrial hygiene and safety practice.
Liver - Irregularities - Based on Human Evidence